|
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| 20/07/16 | Meda : Mylan gets EU approval for Meda purchase, subject to conditions | RE |
| 15/07/16 | Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | - | |
Mårten Österlund
LAW | General Counsel | 69 | 09/12/2014 |
Rainer Weiss
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 25/08/2016 | |
| Director/Board Member | 58 | 25/08/2016 | |
| Chairman | 52 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.81% | +11.96% | +58.61% | +168.13% | 1,077B | |
| +1.51% | +13.19% | +69.61% | +58.63% | 613B | |
| +0.38% | +17.47% | +39.49% | +91.92% | 448B | |
| +0.99% | +4.85% | +28.17% | +22.04% | 332B | |
| -0.14% | +8.04% | +39.85% | +27.27% | 293B | |
| -0.06% | +6.68% | +31.21% | +42.55% | 286B | |
| -0.96% | +7.49% | -28.02% | -40.86% | 215B | |
| +0.62% | +6.80% | +30.10% | +62.92% | 193B | |
| -1.21% | +2.08% | +14.15% | +65.83% | 159B | |
| Average | +0.16% | +8.48% | +31.46% | +55.38% | 401.79B | |
| Weighted average by Cap. | +0.65% | +9.65% | +43.00% | +82.84% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
